Chairman of Holdipharma “Dr. Magdi Hassan declared that Holdipharma and  its affiliates  are committed to supply the Egyptian citizen with  a safe and effective drug  in an affordable price & good quality, and to proceed more in this strategy, we should continue the three years plan that Dr. Mahmoud Mohi Al-Din announced and paved the way  to complete the Development& Modernization for production lines in the affiliated companies with an investment equals L.E. 1.8 billion will be injected  through the next  coming  3 years. The investment will be directed mainly to 3 main axes at the same time:

1-   Production of New products

2-   Renovation of equipments, Machines,  appliances& buildings

3-   Develop & train the Manpower

Dr magdi announced that ‘CID” Company is establishing now a new facility in the industrial zone of 6 October City & it is scheduled to finish the  construction of the building   within 3 years& the investment in Building will cost about 82 Million L.E. from the total investment about L.E. 373 million will be  directed to this project.

At  the same time, there  is another new facility for Misr Company In Abu Zabal district near Cairo  that will be designed to be at the highest standard&  in accordance to the global requirements of GMP& will be  highly equipped with the newest production lines at high technological standards & and the investment devoted to this facility is about  120 Million L.E.& it is consists of 41 separate building dedicated for production, R&D, storage area, engineering services, Management building, Water station for wastewater treatment, car maintenance station, Kinder Garden& Mosque.

Concerning Al-Nasr Company, there is a development plan with an investment of 210 Million L.E. will takes place in  the next 3 years begin with new facility for pharmaceutical products that will start its production at the end of this year.

The Arab Company of Drug also agreed on short term development plan includes renovation of production lines to increase its capacities with an investment of 11.5 Million L.E. this will takes place side by side with the long term plan that will start by building a new  facility complies with the latest global requirements of GMP with  an investment of 1785 Million L.E.